Author: Ben Abid, Fatma; El-Maki, Nada; Alsoub, Hussam; Al Masalmani, Muna; Al-Khal, Abdullatif; Valentine Coyle, Peter; Ben Hadj Kacem, Mohamed Ali; AlGazwani, Hafedh; Al-Thani, Mohammed; Eid Al-Romaihi, Hamad; Al-Hajri, Mohammed; Elmoubashar, Farag
Title: Middle East respiratory syndrome coronavirus infection profile in Qatar: An 8-year experience Cord-id: 3kibznpv Document date: 2021_5_17
ID: 3kibznpv
Snippet: The Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in 2012. The objective of the study was to describe the epidemiology, risk factors, clinical characteristics, and outcome of MERS-CoV in Qatar. A total of 28 cases of MERS-CoV were identified, corresponding to an incidence of 1.7 per 1,000,000 population. Most patients had a history of contact with camels 15, travel to Kingdom of Saudi Arabia 7 or known contact with individuals with confirmed MERS-CoV infection 7. Majority of pa
Document: The Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in 2012. The objective of the study was to describe the epidemiology, risk factors, clinical characteristics, and outcome of MERS-CoV in Qatar. A total of 28 cases of MERS-CoV were identified, corresponding to an incidence of 1.7 per 1,000,000 population. Most patients had a history of contact with camels 15, travel to Kingdom of Saudi Arabia 7 or known contact with individuals with confirmed MERS-CoV infection 7. Majority of patients had acute kidney injury (AKI) 17 and 9 needed renal replacement therapy. All patients were hospitalized, 14 required critical care support. Overall, total of 10 died. The immediate cause of death was multiorgan failure with acute respiratory syndrome (ARDS) 9. MERS-CoV is a rare infection in the State of Qatar. There was no hospital outbreaks or healthcare worker reported infection. The infection causes severe respiratory failure and acute renal failure. Patients with AKI and on ventilator support carry higher risk of mortality.
Search related documents:
Co phrase search for related documents- acute pneumonia and admission length: 1, 2, 3, 4, 5, 6
- acute pneumonia and admission ray: 1, 2
- acute pneumonia and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
- acute pneumonia and logistic regression analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute pneumonia and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute pneumonia and lung infiltrate: 1, 2
- acute pneumonia and lung kidney: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- acute pneumonia and lung kidney present: 1
- acute pneumonia and lymphopenia include: 1, 2
- acute pneumonia respiratory distress syndrome and admission length: 1, 2, 3
- acute pneumonia respiratory distress syndrome and admission ray: 1
- acute pneumonia respiratory distress syndrome and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8
- acute pneumonia respiratory distress syndrome and logistic regression analysis: 1, 2
- acute pneumonia respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute pneumonia respiratory distress syndrome and lung kidney: 1, 2, 3, 4, 5, 6
- acute pneumonia respiratory distress syndrome and lung kidney present: 1
- acute pneumonia respiratory distress syndrome and lymphopenia include: 1
- admission aki and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- admission aki and logistic regression analysis: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date